Switzerland · Delayed Price · Currency is CHF Givaudan Earnings Call Transcripts
Fiscal Year 2026
-
Solid H1 2026 results with 3.6% like-for-like sales growth and strong Fragrance & Beauty momentum, despite CHF 103 million in non-recurring costs. Sequential improvement in Taste & Wellbeing and robust innovation pipeline support confidence in meeting 2030 targets.
Fiscal Year 2025
-
2025 saw robust sales and cash flow growth, with strong performance in Fragrance & Beauty and resilience in Taste & Wellbeing. High-growth markets and local clients drove results, while the outlook targets 4–6% sales growth and >12% free cash flow.
-
Sales grew 6.3% like-for-like in H1 2025, driven by strong volume growth across all segments and geographies, with record EBITDA margin and robust performance in high-growth markets. Strategic expansion and innovation continue, while guidance remains confident for exceeding five-year targets.
Fiscal Year 2024
-
Delivered record free cash flow and resilient growth despite currency headwinds and market challenges, with strong performance in high-growth markets and fine fragrances. Margin improvement and operational efficiency initiatives support a positive outlook for 2024.
-
Sales grew 12.5% like-for-like to CHF 3.7 billion, with EBITDA margin rising to 24.8% and net income up 31%. High growth markets drove performance, and both divisions posted strong volume gains. Margin improvement and innovation remain key focuses.